28 Revista Médica Vozandes
Volumen 34, Número 2, 2023
FRECUENCIA Y CARACTERÍSTICAS CLÍNICAS DE
PACIENTES CON HEPATITIS AUTOINMUNE (...) González Dominguez E, et al.
19. Estrada C. CARACTERIZACIÓN CLÍNICA DE PA-
CIENTES CON HEPATITIS AUTOINMUNE. 2019;1.
20. Feldman M, Lawrance S. Sleisenger and
Fordtran’s Gastrointestinal and Liver Disea-
se ... - Google Libros [Internet]. 2021 [cited
2022 Jun 9]. Available from: https://books.
google.com.ec/books?hl=es&lr=&id=gIrtDw
AAQBAJ&oi=fnd&pg=PP1&dq=.+M.+Feldm
an.+Gastrointestinal+and+liver+Disease.+11
th+ed.+Philadelphia:+Elsevier%3B+2021.&ots
=JMIgKhUJI_&sig=H-pTXIfyl6zmuuqEsnFOlKdlo
8o#v=onepage&q&f=false
21. Higuchi T, Oka S, Furukawa H, Tohma S, Yatsu-
hashi H, Migita K. Genetic risk factors for au-
toimmune hepatitis: implications for phenotypic
heterogeneity and biomarkers for drug respon-
se. Human Genomics 2021 15:1 [Internet]. 2021
Jan 28 [cited 2022 Jun 9];15(1):1–8. DOI: https://
doi.org/10.1186/s40246-020-00301-4 - Available
from: https://humgenomics.biomedcentral.
com/articles/10.1186/s40246-020-00301-4
22. Rahim MN, Miquel R, Heneghan MA. Approach
to the patient with acute severe autoimmune
hepatitis. JHEP Reports. 2020 Dec 1;2(6).
23. Mieli-Vergani G, Vergani D, Czaja AJ, Manns
MP, Krawitt EL, Vierling JM, et al. Autoimmune
hepatitis. Nat Rev Dis Primers [Internet]. 2018
Apr 12 [cited 2022 Jun 9];4. PMID: 29644994
DOI: 10.1038/nrdp.2018.17 Available from:
https://pubmed.ncbi.nlm.nih.gov/29644994/
24. Doycheva I, Watt KD, Gulamhusein AF. Autoim-
mune hepatitis: Current and future therapeutic
options. Liver International [Internet]. 2019 Jun
1 [cited 2022 Jun 9];39(6):1002–13. DOI:10.1111/
liv.14062 Available from: https://onlinelibrary.
wiley.com/doi/full/10.1111/liv.14062
25. Brasileira De Hepatologia Parte S. Recomen-
dações da Sociedade Brasileira de Hepato-
logia Parte I Para Diagnóstico e Tratamento
das Doenças Colestáticas e Hepatite Autoi-
mune. 2015;
26. Lisboa P, Claudia B, Couto A. MANUAL DE
CONDUTAS EM DOENÇAS COLESTÁTICAS E
AUTOIMUNES DO FÍGADO. 2019;
27. Aguilar-Nájera O, Velasco-Zamora JA, Torre
A. Diagnóstico y tratamiento de los síndromes
de sobreposición de hepatitis autoinmune.
Rev Gastroenterol Mex [Internet]. 2015 Apr 1
[cited 2022 Jun 9];80(2):150–9. DOI: 10.1016/j.
rgmx.2015.04.001 Available from: http://www.
revistagastroenterologiamexico.org//es-
diagnostico-tratamiento-sindromes-sobrepo-
sicion-hepatitis-articulo-S0375090615000373
28. Hirscheld GM, Beuers U, Corpechot C, Inver-
nizzi P, Jones D, Marzioni M, et al. EASL Clinical
Practice Guidelines: The diagnosis and mana-
gement of patients with primary biliary cho-
langitis. J Hepatol [Internet]. 2017 Jul 1 [cited
2022 Jun 9];67(1):145–72.DOI:10.1016/j.jhep
Available from: http://www.journal-of-hepa-
tology.eu/article/S0168827817301861/fulltext
29. Rahim MN, Miquel R, Heneghan MA. Ap-
proach to the patient with acute severe au-
toimmune hepatitis. JHEP Reports. 2020 Dec
1;2(6):100149.
30. Komory A. Recent updates on the manage-
ment of autoimmune hepatitis. Clin Mol He-
patol. 2020 Dec 10;1:58–69.
31. Anand L, Choudhury A, Bihari C, Sharma BC,
Kumar M, Maiwall R, et al. Flare of Autoim-
mune Hepatitis Causing Acute on Chronic
Liver Failure: Diagnosis and Response to Cor-
ticosteroid Therapy. Hepatology. 2019 Aug
1;70(2):587–96.
32. Fragua E, Mata M. Trasplante hepático: indi-
caciones y resultados. Sección de Hepato-
logía Unidad de Trasplante Hepático. 2008
May;7:113–7.
33. Hepp K. J, Zapata R, Buckel E, Martínez J,
Uribe M, Díaz JC, et al. General considera-
tions, indications, and contraindications for
liver transplantation in Chile: A multicen-
ter consensus development document.
Rev Med Chil [Internet]. 2008 Jun [cited
2022 Jun 9];136(6):793–804. DOI : 10.4067/
S0034-98872008000600017 Available from:
http://www.scielo.cl/scielo.php?script=sci_
arttext&pid=S0034-98872008000600017&lng=
en&nrm=iso&tlng=en
34. Serrano MT, Lorente S, García-Gil A. Indicacio-
nes del trasplante hepático. 2009; https://
www.aegastro.es/documents/pdf/68_Indica-
ciones_del_trasplante_hepatico.pdf
35. Mack CL, Adams D, Assis DN, Kerkar N, Manns
MP, Mayo MJ, et al. Diagnosis and Manage-
ment of Autoimmune Hepatitis in Adults and
Children: 2019 Practice Guidance and Gui-
delines From the American Association for
the Study of Liver Diseases. Hepatology [Inter-
net]. 2020 Aug 1 [cited 2022 Jun 9];72(2):671–
722. DOI: 10.1002/hep.31065 Available
from: https://onlinelibrary.wiley.com/doi/
full/10.1002/hep.31065
36. Brasileira De Hepatologia Parte S. Reco-
mendações da Sociedade Brasileira de He-
patologia Parte I Para Diagnóstico e Trata-
mento das Doenças Colestáticas e Hepatite
Autoimune. 2015;
37. Manns MP, Lohse AW, Vergani D. Autoimmu-
ne hepatitis – Update 2015. J Hepatol [Inter-
net]. 2015 Apr 1 [cited 2022 Jun 9];62(1):S100–
11. DOI: 10.1016/j.jhep.Available from: http://
www.journal-of-hepatology.eu/article/
S0168827815001658/fulltext
38. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Bu-
rroughs AK, Cancado EL, et al. International
Autoimmune Hepatitis Group Report: review
of criteria for diagnosis of autoimmune hepa-
titis. J Hepatol [Internet]. 1999 [cited 2022 Jun
9];31(5):929–38. PMID: 10580593 DOI: 10.1016/
s0168-8278(99)80297-9 Available from: https://
pubmed.ncbi.nlm.nih.gov/10580593/
39. Hennes EM, Zeniya M, Czaja AJ, Parés A, Da-
lekos GN, Krawitt EL, et al. Simplied criteria for
the diagnosis of autoimmune hepatitis. He-
patology [Internet]. 2008 Jul [cited 2022 Jun
9];48(1):169–76.PMID: 18537184 DOI: 10.1002/
hep.22322 Available from: https://pubmed.
ncbi.nlm.nih.gov/18537184/
40. Manns MP, Czaja AJ, Gorham JD, Krawitt EL,
Mieli-Vergani G, Vergani D, et al. Diagnosis
and management of autoimmune hepatitis.
Hepatology [Internet]. 2010 Jun [cited 2022
Jun 9];51(6):2193–213.PMID: 20513004 DOI:
10.1002/hep.23584 Available from: https://
pubmed.ncbi.nlm.nih.gov/20513004/
41. Gleeson D, Heneghan MA. British Society of
Gastroenterology (BSG) guidelines for mana-
gement of autoimmune hepatitis. Gut. 2011
Dec;60(12):1611–29.
42. Sonthalia N, Rathi PM, Jain SS, Surude RG,
Mohite AR, Pawar S v., et al. Natural History
and Treatment Outcomes of Severe Au-
toimmune Hepatitis. J Clin Gastroenterol [In-
ternet]. 2017 [cited 2022 Oct 22];51(6):548–
56. PMID: 28272079 DOI: 10.1097/
MCG.0000000000000805 Available from:
https://pubmed.ncbi.nlm.nih.gov/28272079/
43. Onji M. Proposal of autoimmune hepatitis pre-
senting with acute hepatitis, severe hepatitis,
and acute liver failure. Hepatol Res [Internet].
2011 Jun [cited 2022 Oct 22];41(6):497–497.PMID:
21554505 DOI: 10.1111/j.1872-034X.2011.00810.x
Available from: https://pubmed.ncbi.nlm.nih.
gov/21554505/
44. Czaja AJ. Autoantibody-negative autoim-
mune hepatitis. Dig Dis Sci [Internet]. 2012
Mar [cited 2022 Oct 22];57(3):610–24.PMID:
22187100 DOI: 10.1007/s10620-011-2017-z
Available from: https://pubmed.ncbi.nlm.nih.
gov/22187100/
45. Josita S, Yoshizawa K, Umemura T, Ohira H,
Takahashi A, Harada K, et al. Clinical features
of autoimmune hepatitis with acute presen-
tation: a Japanese nationwide survey. J Gas-
troenterol [Internet]. 2018 Sep 1 [cited 2022
Oct 22];53(9):1079–88. PMID: 29476251 DOI:
10.1007/s00535-018-1444-4 Available from:
https://pubmed.ncbi.nlm.nih.gov/29476251/
46. Shen Y, Lu C, Men R, Liu J, Ye T, Yang L. Cli-
nical and Pathological Characteristics of Au-
toimmune Hepatitis with Acute Presentation.
Can J Gastroenterol Hepatol [Internet]. 2018
[cited 2022 Oct 22];2018.PMID: 29744332 PM-
CID: PMC5878912 DOI: 10.1155/2018/3513206
Available from: https://pubmed.ncbi.nlm.nih.
gov/29744332/
47. Fallatah HI, Akbar HO, Qari YA. Autoimmune
hepatitis: Single-center experience of clinical
presentation, response to treatment and prog-
nosis in Saudi Arabia. Saudi J Gastroenterol [In-
ternet]. 2010 Apr 1 [cited 2022 Oct 22];16(2):95–
9. PMID: 20339178 PMCID: PMC3016513. DOI:
10.4103/1319-3767.61235 Available from:
https://pubmed.ncbi.nlm.nih.gov/20339178/
48. Zheng L, Liu Y, Shang Y, Han Z, Han Y. Clini-
cal characteristics and treatment outco-
mes of acute severe autoimmune hepatitis.
BMC Gastroenterol [Internet]. 2021 Dec 1
[cited 2022 Oct 22];21(1):1–7 DOI: .10.1186/
s12876-021-01653-4 Available from: https://
bmcgastroenterol.biomedcentral.com/arti-
cles/10.1186/s12876-021-01653-4.
49. Aljumah AA, Al-Ashgar H, Fallatah H, Alb-
enmousa A. Acute onset autoimmune he-
patitis: Clinical presentation and treatment
outcomes. Ann Hepatol [Internet]. 2019 May
1 [cited 2022 Oct 22];18(3):439–44.PMID:
31040094 DOI: 10.1016/j.aohep.2018.09.001
Available from: https://pubmed.ncbi.nlm.nih.
gov/31040094/
50. Aljumah AA, al Ghamdi H, al Alwan A,
Alkhormi A, Kuriry H, Al-Ashgar H, et al. Clinical
Presentation, Treatment Outcome and Pre-
dictors of Severity in Autoimmune Hepatitis: A
Retrospective, Multicenter Experience. J Gas-
troenterol Hepatol Res [Internet]. 2016 Aug
21 [cited 2022 Oct 22];5(4):2147–51. Availa-
ble from: http://www.ghrnet.org/index.php/
joghr/article/view/1818
51. Omagari K, Kinoshita H, Kato Y, Nakata K,
Kanematsu T, Kusumoto Y, et al. Clinical fea-
tures of 89 patients with autoimmune hepatitis
in Nagasaki Prefecture, Japan. J Gastroen-
terol [Internet]. 1999 Apr [cited 2022 Oct
22];34(2):221–6.PMID: 10213122 DOI: 10.1007/
s005350050247 Available from: https://pub-
med.ncbi.nlm.nih.gov/10213122/